Vedana Therapeutics launches to develop migraine therapies
Memento Medicines launches with $93m to develop antibody therapy for retinal diseases
Meteor Biotech joins brain organoids consortium
Can food influence gene activity?
Cells “back up” DNA replication to survive damage
Base to Base biotech podcast 58: Congenital myotonic dystrophy
Lab-grown red blood cells cover all blood types
Researchers discover new therapeutic targets for lithium in Alzheimer’s disease
New research brings personalised treatment for Parkinson’s disease closer
Greywolf Therapeutics and Genomics look to develop first‑in‑class autoimmune diseases treatments
Priority review for potential first approved treatment for warm autoimmune haemolytic anaemia
New first-in-class therapy for chronic graft-versus-host disease approved in Australia